«When the FDA finds significant departures from good clinical practice, those findings are seldom reflected in the peer-reviewed literature, even when there is evidence of data fabrication or other forms of research misconduct.»
«the agency withholds the identity of a clinical trial affected by scientific misconduct»
JAMA Network | JAMA Internal Medicine | Research Misconduct Identified by the US Food and Drug Administration: Out of Sight, Out of Mind, Out of the Peer-Reviewed Literature
«the agency withholds the identity of a clinical trial affected by scientific misconduct»
JAMA Network | JAMA Internal Medicine | Research Misconduct Identified by the US Food and Drug Administration: Out of Sight, Out of Mind, Out of the Peer-Reviewed Literature